New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Bhubaneswar: In a significant move to strengthen women-led urban livelihoods, the Housing & Urban Development…
Konark: The third evening of the Konark Festival 2025 unfolded with vibrant cultural splendour as…
Bhubaneswar: The Odia Language, Literature and Culture Department, in collaboration with the Odisha Sahitya Akademi,…
New Delhi: Odisha has earned national recognition for its outstanding progress in disability rights and…
Bhubaneswar: The 37th Sub-Junior National Badminton Championship began today at the iconic Kalinga Stadium, marking…
Bhubaneswar: In a landmark move reflecting Odisha’s commitment to people-centric governance, the iconic Raj Bhavan…
